Entries by numaferm-admin

NUMAFERM wins Start Me Up! award

Düsseldorf based biotech startup NUMAFERM wins BILANZ start up competition “Start Me Up!” and receives 100.000 Euros. Jury-head, serial-entreapreneur and Silicon-Valley investor Andy Bechtolsheim about the decision: “Three aspects are important for venture capitalists: firstly, the team, secondly, the technology and thirdly, the potential market success. All three factors are important but most important is […]

Deutsche Biotechnologietage 2018, Berlin

NUMAFERM is going participate in the “German-Biotech-Days 2018”, taking place in Berlin 18th to 19th of April. Our CEO, Dr. Christian Schwarz, will hold a presentation at 4pm on April 18th as part of the symposiom on industrial biotechnology: “Think Big. Biomolecules in Large Scale”. We are happy to meet you in Berlin and have […]

TIDES 2018, Boston

NUMAFERM’s CEO Dr. Christian Schwarz is going to take part in the 2018 TIDES Convention, that takes place in Boston in May. TIDES is the largest meeting to accelerate peptide products from early discovery to late-stage development & commercialization. Please get in contact with Christian (christian.schwarz@numaferm.com) in order to pre-arrange one-on-one meetings. We are looking […]

Evonik is investing in NUMAFERM

Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the biotechnology company, which is located in Düsseldorf. The investment was made as part of a seed financing round and also includes investments by High-Tech Gründerfonds, the Business Angels and Qiagen co-founders Detlev Riesner and Jürgen […]

Minister Pinkwart visits NUMAFERM

Prof. Dr. Andreas Pinkwart, NRW Minister for Economy and Digitization, has visited NUMAFERM as part of “Neue Gründerzeit NRW” on August 17. Pinkwart was given an introduction to the innovative production technology of NUMAFERM that perfectly fits to the idea of bioeconomy. The company, investors, Pinkwart and further participants talked about the importance of life-sciences […]

NUMAFERM closes Seed-Round

The Dusseldorf university spin-off NUMAFERM specializes in the biotechnical production of peptides and is able, through its newly developed platform technology, to dramatically reduce costs for this raw material. For the further technological development and an accelerated market entry, NUMAFERM GmbH is now receiving funding in the seven-digit range. High-Tech Gründerfonds (HTGF), Qiagen co-founders and […]